United States - English - NLM (National Library of Medicine)

cspc ouyi pharmaceutical co. ltd - levamlodipine maleate (unii: 12ww9t2ita) (levamlodipine - unii:0p6nlp6806) - conjupri® is indicated for the treatment of hypertension in adults and patients 6 years and older, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including levamlodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of phar

United States - English - NLM (National Library of Medicine)

cspc ouyi pharmaceutical co., ltd. - esomeprazole magnesium (unii: r6dxu4way9) (esomeprazole - unii:n3pa6559ft) - healing of erosive esophagitis esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. for those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole magnesium delayed-release capsules may be considered. maintenance of healing of erosive esophagitis esomeprazole magnesium delayed-release capsules are indicated to maintain symptom resolution and healing of erosive esophagitis. controlled studies do not extend beyond 6 months. symptomatic gastroesophageal reflux disease esomeprazole magnesium delayed-release capsules are indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with gerd in adults and children 1 year or older. esomeprazole magnesium delayed-release capsules are indicated for the reduction in the occurrence of gastric ulcers associated with continuous nsaid therapy

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

cspc ouyi pharmaceutical co., ltd - ceftriaxona (sÓdica) - ceftriaxona (sÓdica)....1,00 g

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

cspc zhongnuo pharmaceutical (shijiazhuang) company limited, china - amoxicillin , enzyme inhibitor - tablets - 500mg + 125mg

Philippines - English - FDA (Food And Drug Administration)

sahar international trading, inc.; distributor: dynasty pharmaceuticals - co-amoxiclav - powder for injection (iv) - 1g/200mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sahar international trading, inc.; distributor: geofman pharmaceuticals subic, inc. - co-amoxiclav - film-coated tablet - 625 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sahar international trading, inc.; distributor: amson pharmaceuticals - co-amoxiclav - tablet - 375 mg

Philippines - English - FDA (Food And Drug Administration)

sahar internatioal trading, inc.; distributor: geofman pharmaceuticals subic, inc. - co-amoxiclav - powder for injection (iv) - 1g/200mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sahar international trading, inc.; distributor: amson pharmaceuticals - co-amoxiclav - film-coated tablet - 625 mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

fuda pharmaceutical co. limited (tanzania), tanzania - benzathine penicillin - powder - 2.4 mu